Innocan Pharma Corporation: Innocan Pharma Files PCT Patent Application for Diabetic Symptoms

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - July 29, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") is pleased to announce that it has

Related Keywords

Jerusalem ,Israel General ,Israel ,Barenholz ,Sachsen Anhalt ,Germany ,United States ,Herzliya ,Tel Aviv ,Canada ,Canadian ,Iris Bincovich ,Innocan Pharma ,Company Or Innocan ,Innocan Pharma Corporation ,Straits Research ,Innocan Pharma Ltd ,European Union ,Hebrew University Of Jerusalem ,Alberta Newsfile Corp ,International Diabetes Federation ,Tel Aviv University ,Pharma Corporation ,Hebrew University ,Professor Barenholz ,Innocan ,Dharma ,Corporation ,Files ,Patent ,Application ,Diabetic ,Symptoms ,